TO THE EDITOR: Holowatz, Thompson-Torgenson, and Kenney (2) made a valuable attempt to highlight the clinical advantages related to the evaluation of cutaneous microvascular function by laser-Doppler flowmetry. Undoubtedly, there are several reasons that favor a noninvasive approach of microvascular responses; however, my personal feeling is that the authors have substantially underestimated problems and drawbacks related to the concerned approach.
although some of them may be, at least in part, endothelially mediated, this phenomenon appears not to be dependent on nitric oxide (1, 4) .
Furthermore, tests of microcirculatory responses in the skin to date have not been correlated with large-vessel disease nor to the behavior of skeletal and cardiac muscle microvessels (1) . For the previously mentioned reasons, the claim that evaluation of cutaneous microvascular function by laser-Doppler flowmetry may provide relevant and reliable information in clinical practice requires careful scrutiny.
